HOME PRODUCTS COMPANY CONTACT FAQ

Research Dictionary Pharma

Sign Up FREE or Login

PYM 00217

a blend of plant extracts for treatment of canine atopic dermatitis

Also Known As:

PYM-00217; PYM00217

Networked: 1 relevant articles (0 outcomes, 1 trials/studies)

Bio-Agent Context: Research Results

Complex Mixtures: 1906
- Biological Products
  - Plant Preparations: 622
    - Plant Extracts: 3916
      - PYM 00217: 1
Pharmaceutical Preparations
- Plant Extracts: 3916
  - PYM 00217: 1

Experts

1.	Carlotti, Didier-Noël: 1 article (08/2006)
2.	Ferguson, Ewan A: 1 article (08/2006)
3.	Grover, Rob: 1 article (08/2006)
4.	Littlewood, Janet D: 1 article (08/2006)
5.	Nuttall, Tim: 1 article (08/2006)

Related Diseases

1.

Atopic Dermatitis (Atopic Eczema)

08/01/2006 - "Dogs with a minimum canine atopic dermatitis extent and severity index (CADESI) of 25 were randomly allocated to receive PYM00217 (100, 200 or 400 mg kg-1 day-1) or placebo for 12 weeks. "
08/01/2006 - "This study evaluated PYM00217, a proprietary blend of plant extracts, in the management of canine atopic dermatitis (AD). "
08/01/2006 - "Management of canine atopic dermatitis using the plant extract PYM00217: a randomized, double-blind, placebo-controlled clinical study."

Related Drugs and Biologics

1.	Plant Extracts